Carmine Muto
Research Subjects
Carmine Muto has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Bernardino Tuccillo
Ospedale Santa Maria di Loreto Mare, Napoli, Italy
6 shared publications- Valeria Calvi
Policlinico Vittorio Emanuele PO Ferrarotto, Catania, Italy
4 shared publications - Giampiero Maglia
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy
3 shared publications Mario Davinelli
Medtronic Clinical Department, Roma, Italy
3 shared publicationsRaffaele Iengo
From the Ospedale S.Maria di Loreto Mare, Napoli, Italy (C.M., R.C., R.I., M.C., B.T.); Casa di cura “Montevergine” Mercogliano (AV), Italy (F.S.); CdC Villa dei Fiori, Acerra (NA), Italy (P.G.); CdC Villa Bianca, Bari, Italy (M.N.); CdC Villa Verde Taranto, Italy (C.L.R.); Ospedale Buon Consiglio Fatebenefratelli, Napoli, Italy (R.S.); Policlinico S. Orsola-Malpighi, Bologna, Italy (I.D.); and Boston Scientific, Milano, Italy (C.C.).
3 shared publicationsRaimondo Calvanese
Ospedale Santa Maria di Loreto Mare, Napoli, Italy
3 shared publications
Latest Publications
- Open Access
- 22 May 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Chronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study
Objective. The aim of the study was to compare the two approaches to chronic right ventricular pacing currently adopted in clinical practice: right ventricular apical (RVA) and non-RVA pacing. Background. Chronic RVA pacing is associated with an increased risk of atrial fibrillation, morbidity, and even mortality. Non-RVA pacing may yield more physiologic ventricular activation and provide potential long-term benefits and has recently been adopted as standard procedure at many implanting centers. Methods. The Right Pace study was a multicenter, prospective, single-blind, nonrandomized trial involving 437 patients indicated for dual-chamber pacemaker implantation with a high percentage of RV pacing. Results. RV lead-tip target location was the apex or the interventricular septum. RVA (274) and non-RVA patients (163) did not differ in baseline characteristics. During a median follow-up of 19 months (25th–75th percentiles, 13–25), 17 patients died. The rates of the primary outcome of death due to any cause or hospitalization for heart failure were comparable between the groups (log-rank test, ), as were the rates of the composite of death due to any cause, hospitalization for heart failure, or an increase in left ventricular end-systolic volume ≥ 15% as compared with the baseline evaluation (secondary outcome, ). After central adjudication of X-rays, comparison between adjudicated RVA (239 patients) and non-RVA (170 patients) confirmed the absence of difference in the rates of primary () and secondary () outcome. Conclusions. In patients with indications for dual-chamber pacemaker who require a high percentage of ventricular stimulation, RVA or non-RVA pacing resulted in comparable outcomes. This study is registered with ClinicalTrials.gov (identifier: NCT01647490).- 22 May 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Open AccessChronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study
Objective. The aim of the study was to compare the two approaches to chronic right ventricular pacing currently adopted in clinical practice: right ventricular apical (RVA) and non-RVA pacing. Background. Chronic RVA pacing is associated with an increased risk of atrial fibrillation, morbidity, and even mortality. Non-RVA pacing may yield more physiologic ventricular activation and provide potential long-term benefits and has recently been adopted as standard procedure at many implanting centers. Methods. The Right Pace study was a multicenter, prospective, single-blind, nonrandomized trial involving 437 patients indicated for dual-chamber pacemaker implantation with a high percentage of RV pacing. Results. RV lead-tip target location was the apex or the interventricular septum. RVA (274) and non-RVA patients (163) did not differ in baseline characteristics. During a median follow-up of 19 months (25th–75th percentiles, 13–25), 17 patients died. The rates of the primary outcome of death due to any cause or hospitalization for heart failure were comparable between the groups (log-rank test, ), as were the rates of the composite of death due to any cause, hospitalization for heart failure, or an increase in left ventricular end-systolic volume ≥ 15% as compared with the baseline evaluation (secondary outcome, ). After central adjudication of X-rays, comparison between adjudicated RVA (239 patients) and non-RVA (170 patients) confirmed the absence of difference in the rates of primary () and secondary () outcome. Conclusions. In patients with indications for dual-chamber pacemaker who require a high percentage of ventricular stimulation, RVA or non-RVA pacing resulted in comparable outcomes. This study is registered with ClinicalTrials.gov (identifier: NCT01647490). - Open Access
- 1 August 2017
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 38 (suppl_1)
P1665Chronic apical and non-apical right ventricular pacing in patients with high-grade atrioventricular block: results of the right pace study
Background/Introduction: Chronic right ventricular apical (RVA) pacing is associated with an increased risk of atrial fibrillation, morbidity and even mortality. Non-RVA pacing may yield a more physiologic ventricular activation and provide potential long-term benefits. Non-RVA pacing has recently been adopted as standard procedure at many implanting centers.
- 1 August 2017
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 38 (suppl_1)
Open AccessP1665Chronic apical and non-apical right ventricular pacing in patients with high-grade atrioventricular block: results of the right pace study
Background/Introduction: Chronic right ventricular apical (RVA) pacing is associated with an increased risk of atrial fibrillation, morbidity and even mortality. Non-RVA pacing may yield a more physiologic ventricular activation and provide potential long-term benefits. Non-RVA pacing has recently been adopted as standard procedure at many implanting centers.
- 1 June 2013
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 6 (3) , 538-545
A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS
Background—: Current recommendations require a QRS duration of ≥120 ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure (HF) of ischemic origin, current indications for defibrillator implantation, and QRS P =0.004). After a median follow-up of 16 months, the CRT defibrillator arm showed a nonsignificant higher survival from HF hospitalization and HF death ( P =0.077), and a significantly higher survival from the combined end point of HF hospitalization, HF death, and spontaneous ventricular fibrillation ( P =0.028). Conclusions—: In this comparison of CRT defibrillator and dual-chamber implantable cardioverter-defibrillator, CRT improved clinical status in some patients with ischemic cardiomyopathy, mild-to-moderate symptoms, narrow QRS duration, and mechanical dyssynchrony on echocardiography. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT01577446.
- 1 June 2013
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 6 (3) , 538-545
A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS
Background—: Current recommendations require a QRS duration of ≥120 ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure (HF) of ischemic origin, current indications for defibrillator implantation, and QRS P =0.004). After a median follow-up of 16 months, the CRT defibrillator arm showed a nonsignificant higher survival from HF hospitalization and HF death ( P =0.077), and a significantly higher survival from the combined end point of HF hospitalization, HF death, and spontaneous ventricular fibrillation ( P =0.028). Conclusions—: In this comparison of CRT defibrillator and dual-chamber implantable cardioverter-defibrillator, CRT improved clinical status in some patients with ischemic cardiomyopathy, mild-to-moderate symptoms, narrow QRS duration, and mechanical dyssynchrony on echocardiography. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT01577446.
- 1 March 2012
- Published by Elsevier in American Heart Journal
- Vol. 163 (3) , 422-429
Low-dose dobutamine test associated with interventricular dyssynchrony: A useful tool to identify cardiac resynchronization therapy responders
- 1 March 2012
- Published by Elsevier in American Heart Journal
- Vol. 163 (3) , 422-429
Low-dose dobutamine test associated with interventricular dyssynchrony: A useful tool to identify cardiac resynchronization therapy responders
- 30 September 2008
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 21 (9) , 1055-1061
End-Diastolic Wall Thickness as a Predictor of Reverse Remodelling After Cardiac Resynchronization Therapy: A Two-Dimensional Echocardiographic Study
- 30 September 2008
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 21 (9) , 1055-1061
End-Diastolic Wall Thickness as a Predictor of Reverse Remodelling After Cardiac Resynchronization Therapy: A Two-Dimensional Echocardiographic Study
- 28 June 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 23 (2) , 121-126
Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy
We evaluated whether the dobutamine stress-echo test can select responders to cardiac resynchronization therapy (CRT). Up to 50% of patients do not respond to CRT. Lack of response may be due to a significant amount of scar or fibrotic tissue at myocardial level. We studied 42 CRT patients. After clinical and echocardiographic evaluation, all patients underwent a dobutamine stress-echo test to assess contractile reserve. Cut-off for the test was an increase of 25% of the left ventricular ejection fraction. Patients were implanted with a CRT–defibrillator and followed up at 6 months. Cut-off for CRT response was a reduction of 15% of left ventricular end-systolic volume. Twenty-five patients responded to CRT; all of them showed presence of contractile reserve. The test showed a sensitivity of 100% and a specificity of 88%. Contractile reserve was a strong predictive factor of response to CRT in the studied population.
- 28 June 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 23 (2) , 121-126
Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy
We evaluated whether the dobutamine stress-echo test can select responders to cardiac resynchronization therapy (CRT). Up to 50% of patients do not respond to CRT. Lack of response may be due to a significant amount of scar or fibrotic tissue at myocardial level. We studied 42 CRT patients. After clinical and echocardiographic evaluation, all patients underwent a dobutamine stress-echo test to assess contractile reserve. Cut-off for the test was an increase of 25% of the left ventricular ejection fraction. Patients were implanted with a CRT–defibrillator and followed up at 6 months. Cut-off for CRT response was a reduction of 15% of left ventricular end-systolic volume. Twenty-five patients responded to CRT; all of them showed presence of contractile reserve. The test showed a sensitivity of 100% and a specificity of 88%. Contractile reserve was a strong predictive factor of response to CRT in the studied population.
- 16 July 2007
- Published by Springer Nature
- p. 117-118
Determination of Left Ventricular Contractile Reserve by Dobutamine Stress Echocardiography To Predict the Response to CRT
- 16 July 2007
- Published by Springer Nature
- p. 117-118
Determination of Left Ventricular Contractile Reserve by Dobutamine Stress Echocardiography To Predict the Response to CRT